Wed, Mar 29, 2017 | updated 08:45 PM IST

Hemophilia can now be treated by simply swallowing capsule

Updated: Nov 29, 2016 14:33 IST

Washington D.C. [USA], Nov. 29 (ANI): Researchers have developed a less expensive, less painful treatment for hemophilia as the disease can now be cured by simply swallowing a capsule.

The researchers describe their system in the issue of the International Journal of Pharmaceutics.

Treatment for hemophilia can now be administered via a biodegradable system, a capsule, giving people affected by the hereditary bleeding disorder hope for a less expensive, less painful treatment option than conventional injections or infusions.

The researchers in the Cockrell School of Engineering at The University of Texas at Austin designed the oral delivery system, which contains micro- and nanoparticles, to carry a protein therapy that treats hemophilia B.

There are approximately 400,000 people worldwide living with either hemophilia A or hemophilia B, both caused by a missing protein in their blood.

Hemophilia B is caused by a missing or defective factor IX, a clotting protein . The bleeding disorder affects people throughout the world, but global accessibility to therapy is limited by cost, the need for trained medical personnel and possible complications associated with needle-based drug administration.

Thousands of people endure multiple injections weekly to keep symptoms, such as excessive bleeding and pain in the joints, at bay and prevent future joint disease.

"While an oral delivery platform will be beneficial to all hemophilia B patients, patients in developing countries will benefit the most," said Sarena Horava, the study's lead author who is a recent Ph.D. graduate from the Cockrell School's McKetta Department of Chemical Engineering and a National Science Foundation graduate research fellow.

"In many developing countries, the median life expectancy forhemophilia patients is 11 years due to the lack of access to treatment, but our new oral delivery of factor IX can now overcome these issues and improve the worldwide use of this therapy."

Horava, who now works at Triton Systems, collaborated with co-author and co-inventor Nicholas A. Peppas, the director of UT Austin's Institute for Biomaterials, Drug Delivery and Regenerative Medicine and a Cockrell School professor who also holds appointments in the Dell Medical School and School of Pharmacy. Katie J. Moy, an undergraduate student in the Cockrell School's Department of Biomedical Engineering, is also a co-author on the study.

Peppas said that alleviating the burden of injections for children was the impetus for the research project, which started about nine years ago.

"My most pressing concern was the treatment of younger patients who suffer from hemophilia and who have to apply injections every two days," Peppas said.

"The original idea of the project was conceived when Dr. Lisa Brannon-Peppas, who at the time was a biomedical engineering faculty member, discussed with me the side effects of the disease and the psychological impact it has on mothers," he added.

Peppas and Horava's work has been patented and builds upon their published and patented system for the oral delivery of human factor IX (hFIX), a prophylactic treatment for hemophilia B patients. That system was successful in transporting hFIX, and it was able to deliver adequate levels of the drug to the target site in the body.

The biggest challenge in delivering hFIX is that it is extremely delicate and unstable in the body's various pH environments. The researchers' new and improved system is designed to capitalize on the body's pH and changes in enzymes inside the gastrointestinal tract for a smooth delivery.

As it moves through the body, the particle-containing capsule resists the major gastric enzyme to remain intact while in the stomach, providing protection for the encapsulated drug. In the small intestine, the capsule begins to swell with the increase in pH and is then degraded by the major intestinal enzyme, slowly releasing the drug over time.

"Based on the current capabilities of this system, approximately two capsules would be equivalent to one injection," Horava said.

"However, we anticipate that we will make further improvements to the delivery capacity of the oral delivery system and therefore decrease the capsule amount," he added

The researchers plan to further test this system before clinical trials. They are working with the UT Austin Office of Technology Commercialization to further advance the technology for clinical use.

The researchers indicate that their ultimate goal is to position this technology for Food and Drug Administration approval.(ANI)

Washington.D.C. [USA], Mar. 29 (ANI): A study finds that gastric acid suppression drugs increase the risk of recurrent Clostridium difficile infection - which causes diarrhea and life-threatening inflammation of the colon.

Full Story >>

Ranchi [India], Mar. 28 (ANI): Health Minister of Jharkhand, Ramchandra Chandravanshi has recently claimed that the state has come a long way from the day when Jharkhand was on 18th number among states as far as their healthcare services were concerned. It now stands third in the country, according to an independent survey.

Full Story >>

Washington D.C. [USA], Mar. 28 (ANI): Exposure to fungal product, called aflatoxin, is believed to cause up to 80 percent of liver cancer cases in many parts of the world.

Full Story >>

Washington D.C. [USA], Mar. 26 (ANI): Attention dog lovers! With just six months of training, a German Shepherd can accurately detect breast cancer, a study finds.

Full Story >>

Washington D.C. [USA], Mar. 26 (ANI): A recent study has found that a sleepless night impairs your ability to interpret subtle expressions of happiness and sadness.

Full Story >>

Washington D.C. [USA], Mar. 26 (ANI): When it comes to new moms' workout programs, less is more and so, according to a Kansas State University researcher, new moms may need a bit more flexibility and support to ease back into exercise after giving birth.

Full Story >>

New approach to diagnosing mental disorders

Updated: Mar 26, 2017 10:48 IST

Washington D.C. [USA], Mar. 26 (ANI): A consortium of psychiatrists and psychologists has proposed a new approach to diagnosing mental disorders.

Full Story >>

Washington D.C. [USA], Mar. 26 (ANI): Boosting natural brain opioids may be a better way to treat anxiety, according to a recent study.

Full Story >>

Fecal transplant offers hope for autistic kids

Updated: Mar 26, 2017 09:37 IST

Washington D.C. [USA], Mar. 26 (ANI): In this new era of medical therapy dawning, fecal transplants are poised to help fight a range of conditions, from deadly superbugs to obesity and now, autism is in the firing line.

Full Story >>

Thiruvallur (Chennai) [India], Mar. 25 (ANI): A highly contagious viral disease of cattle and swine, Foot-and-Mouth Disease (FMD) has affected Karani village on the outskirts of Tamil Nadu's Tiruvallur district.

Full Story >>

New Delhi [India], Mar. 25 (ANI): The findings of the National Family Health Survey 2015-16 confirm what we all knew from clinical evidence - that hypertension has become a major health concern among the Indian population, with as many as 22% Indians hypertensive.

Full Story >>

Washington D.C. [USA], Mar. 25 (ANI): A prescription weight-loss medication can decrease the urge to use opiates such as oxycodone, according to a recent study.

Full Story >>

Washington D.C. [USA], Mar. 25 (ANI): A team of researchers has discovered a new gene that is associated with Tau accumulation, which is one of the defining features of Alzheimer disease (AD).

Full Story >>

Washington D.C. [USA], Mar. 25 (ANI): All it takes is the flip of a protein "switch" within the tiny wire-like capillaries of the brain to increase the blood flow that ensures optimal brain function.

Full Story >>

Washington D.C. [USA], Mar. 25 (ANI): Scientists have found that stem cell therapy repairs damaged lungs - raising hopes of a cure for the crippling chronic obstructive pulmonary disease (COPD) and cystic fibrosis.

Full Story >>

New method can cut dental implant failure

Updated: Mar 25, 2017 09:34 IST

Washington D.C. [USA], Mar. 25 (ANI): A team of researchers has come up with a new method to reduce dental implant failure.

Full Story >>

Washington D.C. [USA], Mar. 25 (ANI): A team of researchers has come up with a fluorogenic probe that can detect the activity of multidrug-resistant pathogens in an assay system.

Full Story >>

Virus hydrophobicity can help purify vaccines

Updated: Mar 25, 2017 07:46 IST

Washington D.C. [USA], Mar. 25 (ANI): A team of researchers has found that hydrophobic proteins on virus surfaces can help purify vaccines.

Full Story >>

Washington D.C. [USA], Mar. 25 (ANI): A team of researchers has shed light on why survivors of childhood brain tumours may be prone to heart disease, stroke, type 2 diabetes and early death.

Full Story >>

New Delhi [India], Mar. 24 (ANI): Continuing its efforts to raise awareness on tuberculosis and its diagnosis, Division of Clinical Microbiology & Molecular Medicine Department of Laboratory Medicine, AIIMS, and BD (Becton Dickinson India) for the third consecutive year organized a symposium today on "challenges in diagnosis and eradication of tuberculosis".

Full Story >>